Drug Makers Urged To Collect Own Excipient Metals Data To Comply With ICH Q3D
Executive Summary
While leveraging published data may help pharmaceutical manufacturers understand the general risks of using excipients with known elemental impurities, it is less helpful in understanding specific risks.